share_log

Ginkgo Bioworks | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARK Investment Management LLC(12.26%)

Ginkgo Bioworks | SC 13G/A:超過5%持股股東披露文件(修正)-ARK Investment Management LLC(12.26%)

SEC announcement ·  01/29 16:04
Moomoo AI 已提取核心訊息
ARK Investment Management LLC, an investment adviser based in Delaware, United States, has filed an amended Schedule 13G with the United States Securities and Exchange Commission on January 29, 2024, indicating a significant ownership stake in Ginkgo Bioworks Holdings, Inc. The filing, which reflects the state of ownership as of December 31, 2023, reports that ARK Investment Management LLC has beneficial ownership of 198,606,619 shares of Ginkgo Bioworks' Class A Common Stock, representing 12.26% of the class. The shares are held in the ordinary course of business, with no intention of changing or influencing the control of the issuer. ARK Investment Management LLC possesses sole voting power over 189,683,331 shares and shared voting power over 5,064,553 shares, with sole dispositive power over the entire 198,606,619 shares reported.
ARK Investment Management LLC, an investment adviser based in Delaware, United States, has filed an amended Schedule 13G with the United States Securities and Exchange Commission on January 29, 2024, indicating a significant ownership stake in Ginkgo Bioworks Holdings, Inc. The filing, which reflects the state of ownership as of December 31, 2023, reports that ARK Investment Management LLC has beneficial ownership of 198,606,619 shares of Ginkgo Bioworks' Class A Common Stock, representing 12.26% of the class. The shares are held in the ordinary course of business, with no intention of changing or influencing the control of the issuer. ARK Investment Management LLC possesses sole voting power over 189,683,331 shares and shared voting power over 5,064,553 shares, with sole dispositive power over the entire 198,606,619 shares reported.
總部位於美國特拉華州的投資顧問方舟投資管理有限責任公司已於2024年1月29日向美國證券交易委員會提交了經修訂的附表13G,表明銀杏生物控股公司擁有大量所有權。該文件反映了截至2023年12月31日的所有權狀況,報告稱,方舟投資管理有限責任公司擁有銀杏生物工程A類普通股198,606,619股的實益所有權,佔全班同學的 12.26%。股票在正常業務過程中持有,無意改變或影響發行人的控制權。方舟投資管理有限責任公司擁有超過189,683,331股股票的唯一投票權,對5,064,553股股票擁有共同投票權,對報告的全部198,606,619股股票擁有唯一的處置權。
總部位於美國特拉華州的投資顧問方舟投資管理有限責任公司已於2024年1月29日向美國證券交易委員會提交了經修訂的附表13G,表明銀杏生物控股公司擁有大量所有權。該文件反映了截至2023年12月31日的所有權狀況,報告稱,方舟投資管理有限責任公司擁有銀杏生物工程A類普通股198,606,619股的實益所有權,佔全班同學的 12.26%。股票在正常業務過程中持有,無意改變或影響發行人的控制權。方舟投資管理有限責任公司擁有超過189,683,331股股票的唯一投票權,對5,064,553股股票擁有共同投票權,對報告的全部198,606,619股股票擁有唯一的處置權。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息